Association of Systemic Comorbidities with Dry Eye Disease

Overview

Journal J Clin Med

Specialty General Medicine

Date 2020 Jul 3

PMID 32610609

Citations 7

Authors

Motoko Kawashima

Masakazu Yamada

Chika Shigeyasu

Kazuhisa Suwaki

Miki Uchino

Yoshimune Hiratsuka

Norihiko Yokoi

Kazuo Tsubota

For The Decs-J For The Decs-J

Affiliations

Soon will be listed here.

Abstract

We investigated the association between dry eye disease and systemic comorbidities, including dry eye subtype, quality of life (QOL) and health utility among patients with dry eye disease. This cross-sectional, observational study enrolled 449 patients with dry eye disease (386 females; mean age, 62.6 ± 15.7 [range, 21-90] years). Ophthalmic examination findings included tear film break-up time (TBUT), Schirmer I value and keratoconjunctival staining score. QOL and health utility were evaluated using the Dry Eye-Related Quality-of-Life Score (DEQS) and Human Utility Index Mark 3 (HUI-3), respectively. Background information, including systemic comorbidities, was obtained. Prevalence of systemic comorbidities was 48.8% (219/449). No significant difference occurred between DEQS and systemic comorbidity. However, patients with dry eye disease and systemic comorbidities (depression and insomnia) exhibited significantly worse ocular surface parameters, particularly regarding TBUT, than those without. Dry eye disease with insomnia or depression comorbidity significantly correlated with friction-related diseases (including conjunctivochalasis or lid wiper epitheliopathy). A high prevalence of several systemic comorbidities occurred in patients with dry eye disease. This study shows an association between ocular signs and systemic comorbidities, particularly depression and insomnia. Ophthalmologists should be aware of patients' systemic comorbidities in the diagnosis and management of dry eye disease.

Citing Articles

The severity of dry eye symptoms and risk factors among university students in Saudi Arabia: a cross-sectional study.

Alqurashi A, Almaghrabi H, Alahmadi M, Alotaibi A, Alotaibi B, Jastaniah A Sci Rep. 2024; 14(1):15149.

PMID: 38956213 PMC: 11219714. DOI: 10.1038/s41598-024-65297-6.

The Influence of Tear Film Quality on Visual Function.

Kastelan S, Gabric K, Mikulicic M, Mrazovac Zimak D, Karabatic M, Gverovic Antunica A Vision (Basel). 2024; 8(1).

PMID: 38535757 PMC: 10974998. DOI: 10.3390/vision8010008.

TFOS lifestyle: Impact of societal challenges on the ocular surface.

Stapleton F, Abad J, Barabino S, Burnett A, Iyer G, Lekhanont K Ocul Surf. 2023; 28:165-199.

PMID: 37062429 PMC: 10102706. DOI: 10.1016/j.jtos.2023.04.006.

The relationship between dry eye disease and anticholinergic burden.

Katipoglu Z, Abay R Eye (Lond). 2023; 37(14):2921-2925.

PMID: 36759707 PMC: 10517132. DOI: 10.1038/s41433-023-02442-x.

Decrease of tear break-up time at Japanese eye clinics during five consecutive years.

Ayaki M, Negishi K Sci Rep. 2022; 12(1):6848.

PMID: 35477771 PMC: 9043507. DOI: 10.1038/s41598-022-11035-9.

References

Wakakura M, Tsubouchi T, Inouye J . Etizolam and benzodiazepine induced blepharospasm. J Neurol Neurosurg Psychiatry. 2004; 75(3):506-7. PMC: 1738986. DOI: 10.1136/jnnp.2003.019869. View

Vu C, Kawashima M, Yamada M, Suwaki K, Uchino M, Shigeyasu C . Influence of Meibomian Gland Dysfunction and Friction-Related Disease on the Severity of Dry Eye. Ophthalmology. 2018; 125(8):1181-1188. DOI: 10.1016/j.ophtha.2018.01.025. View

Schein O, Munoz B, Tielsch J, Bandeen-Roche K, West S . Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997; 124(6):723-8. DOI: 10.1016/s0002-9394(14)71688-5. View

Hirotani Y, Yokoi N, Komuro A, Kinoshita S . [Age-related changes in the mucocutaneous junction and the conjunctivochalasis in the lower lid margins]. Nippon Ganka Gakkai Zasshi. 2003; 107(7):363-8. View

Lemp M . Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995; 21(4):221-32. View

Stapleton F, Alves M, Bunya V, Jalbert I, Lekhanont K, Malet F . TFOS DEWS II Epidemiology Report. Ocul Surf. 2017; 15(3):334-365. DOI: 10.1016/j.jtos.2017.05.003. View

Kawashima M . Systemic Health and Dry Eye. Invest Ophthalmol Vis Sci. 2018; 59(14):DES138-DES142. DOI: 10.1167/iovs.17-23765. View

Wan K, Chen L, Young A . Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye (Lond). 2016; 30(12):1558-1567. PMC: 5177754. DOI: 10.1038/eye.2016.186. View

Korb D, Herman J, Greiner J, Scaffidi R, Finnemore V, Exford J . Lid wiper epitheliopathy and dry eye symptoms. Eye Contact Lens. 2005; 31(1):2-8. DOI: 10.1097/01.icl.0000140910.03095.fa. View

10.

Dana R, Bradley J, Guerin A, Pivneva I, Evans A, Ozer Stillman I . Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study. Am J Ophthalmol. 2018; 198:181-192. DOI: 10.1016/j.ajo.2018.10.001. View

11.

Zheng Y, Wu X, Lin X, Lin H . The Prevalence of Depression and Depressive Symptoms among Eye Disease Patients: A Systematic Review and Meta-analysis. Sci Rep. 2017; 7:46453. PMC: 5388862. DOI: 10.1038/srep46453. View

12.

Sakane Y, Yamaguchi M, Yokoi N, Uchino M, Dogru M, Oishi T . Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire. JAMA Ophthalmol. 2013; 131(10):1331-8. DOI: 10.1001/jamaophthalmol.2013.4503. View

13.

Hackett K, Gotts Z, Ellis J, Deary V, Rapley T, Ng W . An investigation into the prevalence of sleep disturbances in primary Sjögren's syndrome: a systematic review of the literature. Rheumatology (Oxford). 2016; 56(4):570-580. PMC: 5410987. DOI: 10.1093/rheumatology/kew443. View

14.

Tan L, Morgan P, Cai Z, Straughan R . Prevalence of and risk factors for symptomatic dry eye disease in Singapore. Clin Exp Optom. 2014; 98(1):45-53. DOI: 10.1111/cxo.12210. View

15.

Furlong W, Feeny D, Torrance G, Barr R . The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001; 33(5):375-84. DOI: 10.3109/07853890109002092. View

16.

Roh H, Lee J, Kim M, Oh J, Chang M, Chuck R . Systemic Comorbidities of Dry Eye Syndrome: The Korean National Health and Nutrition Examination Survey V, 2010 to 2012. Cornea. 2015; 35(2):187-92. DOI: 10.1097/ICO.0000000000000657. View

17.

Kim K, Han S, Han E, Woo S, Lee J, Yoon J . Association between depression and dry eye disease in an elderly population. Invest Ophthalmol Vis Sci. 2011; 52(11):7954-8. DOI: 10.1167/iovs.11-8050. View

18.

van Bijsterveld O . Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969; 82(1):10-4. DOI: 10.1001/archopht.1969.00990020012003. View

19.

Amano S, Inoue K . Clinic-Based Study on Meibomian Gland Dysfunction in Japan. Invest Ophthalmol Vis Sci. 2017; 58(2):1283-1287. DOI: 10.1167/iovs.16-21374. View

20.

Bron A, Benjamin L, Snibson G . Meibomian gland disease. Classification and grading of lid changes. Eye (Lond). 1991; 5 ( Pt 4):395-411. DOI: 10.1038/eye.1991.65. View